CardieX Limited (CDX.AX)
AUD 0.06
(-7.46%)
AUD 0.06
(-7.46%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -6.71 Million AUD | 71.78% |
| 2023 | -18.97 Million AUD | -71.1% |
| 2022 | -11.36 Million AUD | -114.66% |
| 2021 | -5.19 Million AUD | -72.68% |
| 2020 | -3.36 Million AUD | -8.97% |
| 2019 | -3.56 Million AUD | 7.82% |
| 2018 | -2.88 Million AUD | 33.86% |
| 2017 | -4.44 Million AUD | 17.5% |
| 2016 | -5.38 Million AUD | -85.8% |
| 2015 | -2.8 Million AUD | 6.6% |
| 2014 | -3 Million AUD | -407.17% |
| 2013 | 1.18 Million AUD | 137.95% |
| 2012 | -2.66 Million AUD | -5.58% |
| 2011 | -2.52 Million AUD | -51.29% |
| 2010 | -1.66 Million AUD | 38.27% |
| 2009 | -2.69 Million AUD | 37.74% |
| 2008 | -4.33 Million AUD | 30.93% |
| 2007 | -6.27 Million AUD | -20.91% |
| 2006 | -5.19 Million AUD | -74.04% |
| 2005 | -3.21 Million AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | -3.17 Million AUD | -454.37% |
| 2024 Q4 | -3.17 Million AUD | 0.0% |
| 2024 Q2 | 896.5 Thousand AUD | 0.0% |
| 2024 FY | - AUD | 64.07% |
| 2024 Q1 | 896.5 Thousand AUD | 109.02% |
| 2023 FY | - AUD | -71.1% |
| 2023 Q4 | -3.35 Million AUD | 0.08% |
| 2023 Q2 | -4.28 Million AUD | 0.0% |
| 2023 Q1 | -4.28 Million AUD | -29.37% |
| 2023 Q3 | -3.35 Million AUD | 21.7% |
| 2022 FY | - AUD | -114.66% |
| 2022 Q4 | -3.31 Million AUD | -0.64% |
| 2022 Q3 | -3.29 Million AUD | -24.2% |
| 2022 Q2 | -2.65 Million AUD | 0.0% |
| 2022 Q1 | -2.65 Million AUD | -59.79% |
| 2021 Q2 | -676.23 Thousand AUD | 0.0% |
| 2021 Q1 | -676.23 Thousand AUD | 12.88% |
| 2021 Q4 | -1.65 Million AUD | 4.19% |
| 2021 Q3 | -1.73 Million AUD | -156.09% |
| 2021 FY | - AUD | -72.68% |
| 2020 Q2 | -1.01 Million AUD | 0.0% |
| 2020 FY | - AUD | -8.97% |
| 2020 Q4 | -776.17 Thousand AUD | 1.59% |
| 2020 Q3 | -788.68 Thousand AUD | 22.37% |
| 2020 Q1 | -1.01 Million AUD | -14.62% |
| 2019 Q2 | -677.44 Thousand AUD | 0.0% |
| 2019 Q4 | -886.37 Thousand AUD | -0.08% |
| 2019 FY | - AUD | 7.82% |
| 2019 Q1 | -677.44 Thousand AUD | 18.05% |
| 2019 Q3 | -885.66 Thousand AUD | -30.74% |
| 2018 Q4 | -826.68 Thousand AUD | -0.73% |
| 2018 Q3 | -820.73 Thousand AUD | -83.57% |
| 2018 FY | - AUD | 33.86% |
| 2018 Q2 | -447.08 Thousand AUD | 0.0% |
| 2018 Q1 | -447.08 Thousand AUD | 10.66% |
| 2017 FY | - AUD | 17.5% |
| 2017 Q2 | -1.43 Million AUD | 0.0% |
| 2017 Q1 | -1.43 Million AUD | -28.7% |
| 2017 Q4 | -500.43 Thousand AUD | -1.4% |
| 2017 Q3 | -493.51 Thousand AUD | 65.59% |
| 2016 Q3 | -1.12 Million AUD | 26.63% |
| 2016 Q4 | -1.11 Million AUD | 0.55% |
| 2016 Q2 | -1.52 Million AUD | 0.0% |
| 2016 Q1 | -1.52 Million AUD | -76.35% |
| 2016 FY | - AUD | -85.8% |
| 2015 FY | - AUD | 6.6% |
| 2015 Q4 | -865.97 Thousand AUD | -0.3% |
| 2015 Q3 | -863.35 Thousand AUD | -61.04% |
| 2015 Q2 | -536.1 Thousand AUD | 0.0% |
| 2015 Q1 | -536.1 Thousand AUD | 28.12% |
| 2014 Q4 | -745.86 Thousand AUD | -2.75% |
| 2014 Q1 | -736.04 Thousand AUD | -589.42% |
| 2014 FY | - AUD | -407.17% |
| 2014 Q2 | -736.04 Thousand AUD | 0.0% |
| 2014 Q3 | -725.87 Thousand AUD | 1.38% |
| 2013 Q3 | -105.83 Thousand AUD | -115.08% |
| 2013 Q2 | 701.89 Thousand AUD | -0.0% |
| 2013 Q4 | -106.76 Thousand AUD | -0.88% |
| 2013 FY | - AUD | 137.95% |
| 2013 Q1 | 701.89 Thousand AUD | 255.69% |
| 2012 Q2 | -450.83 Thousand AUD | 38.42% |
| 2012 Q4 | -450.83 Thousand AUD | 0.0% |
| 2012 Q3 | -450.83 Thousand AUD | 0.0% |
| 2012 Q1 | -732.07 Thousand AUD | 0.0% |
| 2012 FY | - AUD | -5.58% |
| 2011 Q1 | -263.55 Thousand AUD | 0.0% |
| 2011 Q4 | -732.07 Thousand AUD | 0.0% |
| 2011 FY | - AUD | -51.29% |
| 2011 Q3 | -732.07 Thousand AUD | 0.0% |
| 2011 Q2 | -732.07 Thousand AUD | -177.77% |
| 2010 Q2 | -263.55 Thousand AUD | 30.09% |
| 2010 Q3 | -263.55 Thousand AUD | 0.0% |
| 2010 Q1 | -377 Thousand AUD | 0.0% |
| 2010 FY | - AUD | 38.27% |
| 2010 Q4 | -263.55 Thousand AUD | 0.0% |
| 2009 Q2 | -377 Thousand AUD | 57.86% |
| 2009 Q4 | -377 Thousand AUD | 0.0% |
| 2009 Q1 | -894.75 Thousand AUD | 0.0% |
| 2009 Q3 | -377 Thousand AUD | 0.0% |
| 2009 FY | - AUD | 37.74% |
| 2008 Q1 | -1.31 Million AUD | 0.0% |
| 2008 Q2 | -894.75 Thousand AUD | 31.84% |
| 2008 Q3 | -894.75 Thousand AUD | 0.0% |
| 2008 FY | - AUD | 30.93% |
| 2008 Q4 | -894.75 Thousand AUD | 0.0% |
| 2007 Q2 | -1.31 Million AUD | -26.29% |
| 2007 Q3 | -1.31 Million AUD | 0.0% |
| 2007 Q4 | -1.31 Million AUD | 0.0% |
| 2007 FY | - AUD | -20.91% |
| 2007 Q1 | -1.03 Million AUD | 0.0% |
| 2006 Q3 | -1.03 Million AUD | 0.0% |
| 2006 Q1 | -1.41 Million AUD | 0.0% |
| 2006 FY | - AUD | -74.04% |
| 2006 Q2 | -1.03 Million AUD | 26.77% |
| 2006 Q4 | -1.03 Million AUD | 0.0% |
| 2005 Q4 | -1.41 Million AUD | 0.0% |
| 2005 Q2 | -1.41 Million AUD | 0.0% |
| 2005 FY | - AUD | 0.0% |
| 2005 Q3 | -1.41 Million AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| 4DMedical Limited | -36.06 Million AUD | 81.39% |
| Adherium Limited | -11.56 Million AUD | 41.961% |
| Aroa Biosurgery Limited | -7.36 Million AUD | 8.807% |
| Atomo Diagnostics Limited | -5.42 Million AUD | -23.755% |
| Anteris Technologies Ltd | -66.9 Million AUD | 89.968% |
| Control Bionics Limited | -5.15 Million AUD | -30.12% |
| Compumedics Limited | 2.78 Million AUD | 340.654% |
| Cochlear Limited | 579.5 Million AUD | 101.158% |
| CleanSpace Holdings Limited | -3.49 Million AUD | -92.217% |
| Cyclopharm Limited | -3.03 Million AUD | -121.155% |
| EMVision Medical Devices Ltd | -2.09 Million AUD | -220.956% |
| Nova Eye Medical Limited | -5.97 Million AUD | -12.257% |
| HeraMED Limited | -3.97 Million AUD | -68.976% |
| Imricor Medical Systems, Inc. | -21.87 Million AUD | 69.311% |
| ImpediMed Limited | -22.05 Million AUD | 69.562% |
| InhaleRx Limited | -1.41 Million AUD | -374.757% |
| LBT Innovations Limited | -4.04 Million AUD | -65.766% |
| Micro-X Limited | -14.35 Million AUD | 53.231% |
| Neurotech International Limited | -8.24 Million AUD | 18.585% |
| OncoSil Medical Limited | -11.97 Million AUD | 43.957% |
| PolyNovo Limited | 5.17 Million AUD | 229.823% |
| Respiri Limited | -7.04 Million AUD | 4.795% |
| SomnoMed Limited | -2.32 Million AUD | -188.234% |
| Universal Biosensors, Inc. | -9.09 Million AUD | 26.166% |
| Uscom Limited | -1.5 Million AUD | -344.696% |
| Visioneering Technologies, Inc. | -4.91 Million AUD | -36.492% |